HHS/FDA open Indian offices
This article was originally published in The Tan Sheet
Executive Summary
Health and Human Services Secretary Mike Leavitt and FDA Commissioner Andrew von Eschenbach announce Jan. 15 the agencies have offices established in New Delhi, and Mumbai, India. Ten HHS/FDA officials will be assigned in India "to work closely with industries that ship food and medical products to the United States, to improve safety and quality, which will facilitate the smooth flow of trade," HHS says. FDA also has a presence in China, Central America and Europe. As part of its Beyond Our Borders Initiative, the agency says it will expand in 2009 to Mexico, the Middle East and South America and open additional European sites (1"The Tan Sheet" Jan. 28, 2008, p. 3)
You may also be interested in...
FDA Eyes Five Global Regions For Permanent Outposts – Commissioner
FDA is in the early stages of developing "boots on the ground" programs in five regions overseas in an effort to improve the quality of imported products at their source, Commissioner Andrew von Eschenbach said Jan. 24 at a media briefing on food safety issues
HHS Watchdog Blesses Proposed Gift Card Giveaway To Encourage Test Returns
A proposal that would give some patients gift cards in exchange for returning a screening test sample would not violate anti-kickback law because it doesn’t encourage medically unnecessary services, HHS-OIG says.
GSK Boosts Its Infectious Disease Portfolio With Brexafemme License
The pharma licensed global rights to Scynexis’s Brexafemme, a first-in-class triterpenoid antifungal approved for treat and prevent recurrence of vaginal yeast infections, for $90m up front.